Apr 2023
$450 Million
![](https://s33007.pcdn.co/wp-content/uploads/2023/04/biocryst-pharmaceuticals-768x427.png)
Jan 2023
$150 Million
![](https://s33007.pcdn.co/wp-content/uploads/2023/01/alphatec-holdings.png)
Oct 2022
$100 Million
![scPharmaceuticals logo](https://s33007.pcdn.co/wp-content/uploads/2022/12/scPharmaceuticals-768x86.jpg)
Aug 2022
$60 Million
![](https://s33007.pcdn.co/wp-content/uploads/2020/02/TransMedics-Group-Inc.jpg)
Apr 2022
$225 Million
![](https://s33007.pcdn.co/wp-content/uploads/2020/02/Establishment-Labs.jpg)
Mar 2022
$100 Million
![](https://s33007.pcdn.co/wp-content/uploads/2020/02/UroGen-Pharma-Ltd.jpg)
Our primary goals as an organization are achieved through adhering to our core values of vision, empathy, sustainability and tenacious teamwork in pursuit of our clients’ interests.